Adlai Nortye (ANL) Stock News
$ANL · NASDAQ · 2 stories in 30 days$11.22
1D −7.24%1W −22.05%1M −22.10%
BORSA has published 2 stories on Adlai Nortye (ANL) in the past 30 days. BORSA’s news read on ANL is bullish at 65/100, unchanged over 24 hours, based on 2 company events over the past 7 days. ANL last closed at $12.09 on Oct 15, down 22.05% over five sessions and down 22.10% over the past month.
The wire on $ANL
newest first · updated · direct subject stories onlyAdlai Nortye Group secures cetuximab supply from Lilly and Merck KGaA for trial sites
Adlai Nortye Group secures cetuximab supply from Lilly and Merck KGaA for trial sites.
bullish 70 · impact 40